Safety and Preliminary Efficacy of 'Ready to Administer' Cytomegalovirus ( CMV)-Specific T Cells for the Treatment of Patients with Refractory CMV Infection

Tzannou Ifigeneia; Leung Kathryn S.; Martinez Caridad; Naik Swati; Gottschalk Stephen; Gee Adrian P.; Grilley Bambi; Watanabe Ayumi; Leen Ann M.; Kakarla Sunitha; Omer Bilal

首页> 外文期刊>Blood: The Journal of the American Society of Hematology >Safety and Preliminary Efficacy of 'Ready to Administer' Cytomegalovirus ( CMV)-Specific T Cells for the Treatment of Patients with Refractory CMV Infection

【24h】

Safety and Preliminary Efficacy of 'Ready to Administer' Cytomegalovirus ( CMV)-Specific T Cells for the Treatment of Patients with Refractory CMV Infection

机译：“准备使用”巨细胞病毒（CMV）特异的T细胞治疗难治性CMV感染的安全性和初步疗效

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Blood: The Journal of the American Society of Hematology 》 |2016年第22期| 共5页
作者
Tzannou Ifigeneia; Leung Kathryn S.; Martinez Caridad; Naik Swati; Gottschalk Stephen; Gee Adrian P.; Grilley Bambi; Watanabe Ayumi; Leen Ann M.; Kakarla Sunitha; Omer Bilal;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Safety and Preliminary Efficacy of "Ready to Administer" Cytomegalovirus ( CMV)-Specific T Cells for the Treatment of Patients with Refractory CMV Infection [J] . Tzannou Ifigeneia, Leung Kathryn S., Martinez Caridad, Blood: The Journal of the American Society of Hematology . 2016 ,第22期

机译：“准备使用”巨细胞病毒（CMV）特异的T细胞治疗难治性CMV感染的安全性和初步疗效
2. CMV INFECTION WITH SIGHT THREATENING CMV RETINITIS REFRACTORY TO CONVENTIONAL TREATMENT: SALVAGE THERAPY WITH AUTOLOGOUS CMV-SPECIFIC T CELLS - A CASE REPORT [J] . Herrmann M., Gary R., Bosch J., Transplant international : . 2019 ,第S3期

机译：CMV感染威胁威胁CMV视网膜炎难以常规治疗：救助治疗自体CMV特异性T细胞 - 一个案例报告
3. Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality [J] . Liu J., Kong J., Chang Y. J., Clinical microbiology and infection: European Society of Clinical Microbiology and Infectious Diseases . 2015 ,第12期

机译：同种异体造血干细胞移植后患有难治性巨细胞病毒（CMV）感染的患者极易患CMV疾病和非复发性死亡
4. Microfluidic device for rapid detection of cytomegalovirus (CMV) by sequence-specific hybridization of PCR-amplified CMV-DNA [C] . Briones, M.P., Yamashita, . 2006

机译：通过PCR扩增的CMV-DNA的序列特异性杂交快速检测巨细胞病毒（CMV）的微流体装置
5. Human cytomegalovirus infection in human umbilical vein endothelial cells; human cytomegalovirus infection in hematopoietic progenitor cells: Model of HCMV latency [D] . Zhuravskya, Tatiana. 1997

机译：人脐静脉内皮细胞中的人巨细胞病毒感染；造血祖细胞中人类巨细胞病毒感染：HCMV潜伏期模型
6. Adoptive Immunotherapy with CMV Specific Cytotoxic T Lymphocytes for Stem Cell Transplant Patients with Refractory CMV Infections [O] . Lei Bao, Mort Cowan, Kimberly Dunham, -1

机译：用CMV特异性细胞毒性T淋巴细胞用于干细胞移植患者难治性CMV感染的耐用免疫疗法
7. Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality [O] . Liu J., Kong J., Chang Y.J., 2015

机译：同种异体造血干细胞移植后患有难治性巨细胞病毒（CMV）感染的患者极易患CMV疾病和非复发性死亡
8. Development of Antiviral Drugs for Treatment of Cytomegalovirus (CMV) Infections, Particularly in AIDS (Acquired Immuno-Deficiency Syndrome) and Other Immunosuppressed Patients. Annual Report July 1, 1985-June 30, 1986 [R] . Wright, G. E. , Medveczky, P. 1986

机译：用于治疗巨细胞病毒（CmV）感染的抗病毒药物的开发，特别是在艾滋病（获得性免疫缺陷综合症）和其他免疫抑制患者中。年报1985年7月1日至1986年6月30日

Safety and Preliminary Efficacy of 'Ready to Administer' Cytomegalovirus ( CMV)-Specific T Cells for the Treatment of Patients with Refractory CMV Infection

著录项

相似文献

相关主题

期刊订阅